Chapter 7: Bt Toxins & Microbial Insecticides
Welcome to Last Minute Lecture.
This free chapter overview is designed to help students review and understand key concepts.
These summaries supplement not replaced the original textbook and may not be redistributed or resold.
For complete coverage, always consult the official text.
Welcome to the Deep Dive, where we take a stack of knowledge and distill it into the most essential and surprising takeaways custom made for you.
Today, we are wading into a microbial revolution that has completely reshaped global agriculture and public health.
We're taking on a centuries -old conflict between humanity and the insect world.
We are conducting a forensic molecule -by -molecule examination of Bacillus thuringiensis, or BT, and the potent, incredibly specific toxins it produces.
That's right.
If you are studying applied microbiology, biotechnology, or even entomology, BT is, well, it's a cornerstone concept.
It represents one of the ultimate success stories of how targeted biological control can replace broad -spectrum chemical warfare.
But before we get into the cool science, we have to start by framing the scale of the crisis BT was designed to solve.
And what a crisis it is.
I mean, the use of chemical agents against insects really ramped up in the mid -1800s.
And we're talking about substances that, looking back, seem wildly toxic.
Oh, absolutely.
Heavy metal compounds like arsenic, for instance.
Exactly.
And this evolved into the highly persistent organochlorines and then the organophosphates of the 20th century.
The sheer intensity of this chemical arms race is just staggering.
Just over two decades ago, in 2001 alone,
global sales of chemical insecticides reached, what, about $9 .1 billion?
$9 .1 billion.
And that represented over 1 .3 million pounds of active ingredients dispersed across the planet.
When you look at those numbers, it sounds like we're winning the war.
But relying exclusively on these chemical methods comes with tremendous mounting disadvantages.
The source material is very clear on this.
The single greatest problem facing applied entomology right now is pest resistance.
Which is really just selective evolution in action, right?
Precisely.
We apply a widespread chemical agent across millions of acres, and we inadvertently confer a massive, life -saving evolutionary advantage to any pest that happens to possess a natural genetic ability to detoxify or just ignore that compound.
They survive, they breed, and they pass that resistance on.
And pretty soon, the chemical is useless.
The classic kind of depressing example here is the common housefly, Musca domestica.
Globally, strains have developed resistance to virtually every type of chemical insecticide we have ever thrown at them.
This forces us into an incredibly costly, constant, and well, ultimately, a losing arms race to develop the next generation of toxins.
And beyond that costly arms race, there's the collateral damage.
The unintended consequences are devastating.
We call them non -target effects.
If you use a broad -spectrum chemical that just indiscriminately wipes out all insects in a field, including the good guys, including the desirable predators that naturally keep certain pest populations in check,
you inadvertently trigger an explosive multiplication of secondary pests.
These pests, previously benign, suddenly have no natural enemies and become a huge problem.
This cycle forces us to use even more chemicals.
And finally, the environmental toxicity and persistence of some of these older compounds, that's the third major headache.
Exactly.
Organochlorines, for instance, persist in the environment for years, biomagnifying up the food chain.
This toxicity and persistence is why so many older chemicals have been entirely abandoned by developed nations.
And it's why developing new, safer materials that meet modern regulatory hurdles is now prohibitively expensive for chemical companies.
It's simply not sustainable.
So the solution is clearly not to look for another magic chemical bullet, but to diversify the attack.
It absolutely has to be diversified.
The hope lies in what we call integrated pest management, or IPM, programs.
These are holistic strategies that rely on multiple simultaneous interventions to control insect populations without relying solely on massive chemical inputs.
This means maximizing the role of natural enemies, like introducing desirable predators, leveraging cultural manipulations, using host plant resistance, and most importantly for our deep dive today, employing insect diseases, specifically microbial agents like bacteria and viruses.
Microbial pest control agents sound perfect on paper.
So why aren't they everywhere?
They are highly attractive because they often have a naturally narrow host range, which dramatically reduces the random destruction of beneficial insects.
And they generally pose less toxicity risk to vertebrates.
However, despite these attractive features, microbial agents make up less than 1 % of the total global insecticide sales.
They are a minuscule share of the market.
But this is where Bacillus thuringiensis punches far above its weight.
It does.
And that accounts for over 90 % of that tiny microbial share, making it the dominant player in biological control.
We have been using bed in its traditional form as a spray dusted onto crops since the 1920s, but its role absolutely exploded after 1996 with the commercial introduction of transgenic crops.
We're talking about corn, cotton, and soybeans engineered to express the bettoxin internally.
By 2002, just six years later, over 35 million acres of these engineered crops were planted worldwide.
It was a rapid, dramatic shift in agriculture.
That dual application, the traditional surface spray and the genetically engineered internal resistance, is why this specific soil bacterium and its insecticidal proteins are now subjects of such intense examination globally.
Our mission in this deep dive is to unpack the biology the complex, almost molecularly elegant mechanism of its toxicity and the revolutionary technology behind its deployment, giving you, the learner, the precise details you need to understand this field.
Okay, let's start with the origin story of this organism.
When and where did the world first recognize Bacillus thuringiensis?
The history of vina begins in the early 20th century.
And interestingly, it started with a mysterious disease in a culturally significant insect,
the silkworm Balmix mori.
In Japan in 1901, a bacteriologist named Shigetan Ishiwara isolated a bacterium responsible for a disease called Flashery.
This literally meant the silkworms became soft and flaccid.
Ishiwara named the organism Bacillus soto.
So the disease was known for a while, but the recognition of the specific organism that gives us the name we use today came a decade later.
Exactly.
In 1911 in Germany, Ernst Berliner isolated a similar Bacillus from an infestation of the Mediterranean flower moth and Augusta canela.
Berliner named his isolate B thuringiensis after the German province of Turin.
For the next 60 years or so, Brannet was known almost exclusively for strains that were pathogenic only to lepidoptera moths and butterflies.
It showed very little activity against other economically important pests like mosquitoes or beetles.
Wait, 60 years of only lepidoptera specific strains.
Why did the scientific community take so long to find the other pathotypes?
I mean, was the biodiversity just not there?
Were they not looking?
That's a great question, and the research points squarely to the latter.
The change came purely from necessity, a recognition of the urgent global need for new biological agents to control major disease -causing insects, especially those that spread to human pathogens.
Researchers began active, dedicated searching, recognizing that these diverse pathogens might not be rare, but were just highly specialized and difficult to find.
And the payoff of that active search was dramatic in the mid -1970s with the discovery of B thuringiensis varn Israelensis, or BTI.
It's truly an incredible moment in applied microbiology, detailed by Dr.
Joel Margulit.
In the mid -1970s, he and Dr.
Tahori were actively surveying Israel for biocontrol agents against mosquitoes.
In August 1976, near Kibbutz Zelim in the central Negev desert, they stumbled upon an unusual site, a small shallow pond with brackish water and a heavy organic load.
The critical observation was that the water surface was covered by a thick carpet of dead and dying colex pipiens mosquito larvae.
A mass die -off, an epidemic in animals, what we call an epizootic situation, a natural event leading directly to a scientific discovery.
Precisely.
They took a sample, isolated and purified the bacteria from that decomposing mess, and found this entirely new pathotuk.
All known cultures of BTI today trace back to that single original colony, designated ONR 60A.
The significance was recognized immediately because blood -sucking dipteran insects, mosquitoes and blackflies are the primary vectors for diseases like malaria, which even today still accounts for 200 to 300 million cases annually.
BTI quickly became, and remains, a crucial tool for controlling these vectors worldwide.
So the search was immediately broadened, and they started finding other pathotypes relatively quickly once they knew what they were looking for.
Absolutely.
Just seven years later, in 1983, they discovered B.
thringiensis vartinebrionis.
This strain was effective against coliopterum pests beetles.
This was critical because it targets the notoriously difficult -to -control Colorado potato beetle, a pest known for rapidly developing resistance to nearly every chemical insecticide available.
This discovery showed that the potential of BTI extended beyond just the traditional moths and butterflies.
Let's get to the fundamental nature of this organism.
We always refer to Belit as a soil bacterium.
That's right.
It is a gram -positive bacterium that lives primarily in the soil, which is its natural reservoir.
It operates with a dual metabolism.
It can grow by digesting dead organic matter — that's its saprophytic metabolism — but it can also colonize and kill living insects through its parasitic metabolism.
You find it commonly in soil samples, but also in stored grain or even the dust of silkworm -rearing houses.
This raises a fascinating kind of counterintuitive question.
If Belit produces these incredibly potent targeted toxins and lives in the soil where insects crawl, why are we constantly seeing these massive natural episodics everywhere?
This is a major insight reinforced by the research.
Natural infections or epizootics are actually quite rare, but appears to have a very low capacity to spread through insect populations on its own.
Researchers have shown that if you cage healthy larvae with infected dying larvae, hardly any of the healthy ones can track the infection.
So despite being a biological control agent, it operates more like a chemical insecticide.
It doesn't spread like a virus.
That is the core conclusion.
For break to be effective in agriculture, it must be delivered to the host at a lethal dose, usually through external application or through engineered plants.
It requires ingestion.
It doesn't typically spread naturally like a contagious disease agent would.
When researchers classify the thousands of strains they have collected, they use different markers.
But the one that matters most for application is the pathotype.
Precisely.
We can use flagellar antigens to give us serotypes or subspecies, which helps identify a strain, but the classification that dictates how we use it is based purely on its pathotype, meaning its insecticidal range.
This classification groups strains based on what insect order they target.
You have categories like Lepidoptera -specific, Dipteran -specific, and Coleopteran -specific strains, as well as strains that cross boundaries, active against both Lepidoptera and Diptera, for example, or strains that show no known toxicity to insects at all.
This functional specificity is what allows us to design targeted pest control programs.
Understanding the diversity and discovery of deutes sets the table.
Now we move into the core science, the mechanism.
We have to go from the physical structure of the bacterium, that spore, to the molecular steps that ultimately cause the insect's death.
Let's start with the physical components.
What makes the bacterium deadly?
Well, we've known since 1915 that the toxicity is completely tied to the bacteria's ability to sporulate.
If a culture hadn't completed sporulation, it wasn't toxic to silkworms.
Once researchers made that connection in the 1950s, the toxic substance became obvious, the perisporal crystalline inclusion bodies.
These crystalline structures are what make beet unique among many bacillus species, and they're even visible under a simple light microscope.
Exactly.
During sporulation, a process that takes about eight hours alongside the development of the dormant spore, the bacterium produces these dense geometric inclusion bodies.
Typically, it forms a large bipyramidal crystal and sometimes a smaller cuboidal crystal right beside it.
Chemically, these crystals are proteins that hold inactive molecules we call
protoxins.
Collectively, we call these proteins del delta endotoxins.
This is crucial.
The actively growing vegetative cells lack these crystals, and therefore, they are completely harmless to insects.
Only the sporulated cell with the crystal is deadly.
So the insect has to consume a specific life stage of the bacterium.
Let's walk through the four elegant molecular stages that turn that inactive crystal into a lethal weapon.
We could use the traditional application of BTS, a dry powder like DAPEL made of sporulated cells as our example.
A perfect scenario.
The dry powder containing crystals and spores is dusted onto the leaf surface and then ingested by a feeding larva.
Stage one, activation.
The insect turns its own chemistry against itself.
The crystalline inclusions, which are large proteins ranging from 70 to 145 kilosea, are inactive protoxins.
They must first dissolve.
This happens in the insect's mid -gut juices, which are incredibly alkaline, especially in Lepidoptera, where the pH can range from 9 .5 to 10 .5.
Once dissolved, the proteins are immediately attacked by the insect's own digestive enzymes, the gut proteases.
So the high pH is necessary to dissolve the crystal, and the digestive enzymes are necessary to chop the protein into its lethal form.
It's a true biological Trojan horse.
Precisely.
The insect's proteases like trypsins, chymotrypsins, or cysteine proteases, depending on the insect order, cleave the mass of protoxins.
This cleavage generates the smaller active protein toxins.
These active fragments are all surprisingly uniform, clustering around 60 to 70 kilodey.
Research has shown that the mature killer part of the toxin resides entirely within the amino terminal 62 to 70 kilodimer portion of the original protoxin.
The rest of the large C -terminal end, starting around residue 700, shows high homology across different protoxins, suggesting its only job is crystal formation.
It's fascinating how specific this initial activation step is.
It is the first checkpoint for specificity.
The toxicity is highly dependent on high mid -gut pH and the specific type of proteolytic enzymes present in different insect orders.
If the gut isn't alkaline enough, the crystal doesn't dissolve.
If the right enzymes aren't there to make the lethal cut, the toxin doesn't activate.
Okay, we have the active 60 to 70 kilodey toxin floating free in the gut.
What's the next obstacle?
Stage two, binding to specific receptors.
The active toxin first has to navigate the peritrophic membrane, the semi -permeable lining that protects the gut wall.
Once through, its entire success hinges on its ability to recognize and bind with extremely high affinity to specific receptor molecules located on the epithelial cells of the mid -gut wall.
What are these receptors?
Are they unique to insects?
They are specialized and they fall into two major categories, glycoproteins and glycolipids.
In many lepidopter, like the tobacco hornworm, specific cell adhesion molecules called cadherins act as receptors for toxins like cry 1A.
Crucially, the receptor version of the cadherin is only expressed during the larval feeding stage, meaning the toxin is highly specific not just to the species but to the vulnerable life stage.
That is surgically precise targeting.
Absolutely.
Another vital glycoprotein receptor is aminopeptidase N, a large 120 -keto -data protein.
The high affinity binding often involves a specific sugar moiety attached to APN called N -acetyl -P -galactosamine.
And the discovery of glycolipid receptors came, surprisingly, from studies in nematodes, right?
That's one of the great side discoveries of BC research.
In the nematode C.
elegans, which feeds on soil bacteria,
scientists demonstrated that specific
glycosfingolipids function as receptors for toxins like cry 5B.
The minimum essential component required for that toxicity is a specific carbohydrate signature, a core tetrasaccharide linked to a ceramide molecule.
The critical part for human safety is that this specific core structure is conserved across invertebrates, nematodes, and insects, but is completely absent invertebrates.
So the toxin is designed to hit a biochemical target that simply doesn't exist in mammals or birds.
Exactly.
It's highly target specific because the architecture of the receptors is conserved only in the vulnerable target group.
Now, why two types of receptors?
The
glycoprotein receptors like APN or cadherins act to position or cluster the cry protein molecules on the cell surface.
This clustering is essential to facilitate the next irreversible step, which is stage three, formation of transmembrane pores.
Once the toxin binds to these clustered receptors, it undergoes a dramatic conformational change, shifting its shape.
This change allows it to insert into the plasma membrane and this insertion is irreversible.
Multiple toxin molecules then they oligomerize to form caisson selective pores.
These pores are incredibly small, perhaps only 10 to 20 A's in diameter.
So they are punching microscopic holes in the cell wall.
What's the consequence of that small hole?
It immediately obliterates the ion permeability barrier that the cell relies on to maintain its stability.
This rapid destruction of the barrier leads to an influx of positive ions, which in turn causes a massive influx of accompanying water molecules.
The result is rapid visual destruction.
We can see through microscopy that the intestinal cells swell dramatically, lose all control of permeability, and eventually lease or rupture.
And the physiological consequence?
Immediate gut paralysis.
The feeding stops almost instantly after the crystals are ingested because the insect loses its ability to regulate its gut function.
The microvilli, the tiny finger -like projections on the epithelial cells disappear almost immediately.
The whole system shuts down.
And finally, stage four, bacteremia, the coup de glace.
With the gut lining destroyed, a clear path is opened into the insect's circulatory system, the hemolymph, what you could call insect blood.
The vegetative B thuringiensis bacteria, which have germinated from the ingested spores, can now easily move from the gut into the hemolymph.
This resulting bacteremia, combined with acute starvation and intoxication, leads to the death of the larva typically within one to three days.
Now here is the most counterintuitive part of this whole mechanism.
The spores might not be the actual killers.
That's the surprising finding from studies on insects like the gypsy moth.
In some cases, B cannot actually kill the larvae on its own.
Mortality appears to be highly dependent on the presence of indigenous enteric bacteria that already live harmlessly in the insect's gut, like enterobacter spin.
Wait, the toxin's job is just to open the door.
Exactly.
These indigenous bacteria, once they gain access to the nutrient -rich hemolymph through the tissue damaged by the bait toxin, multiply rapidly and cause the fatal intoxication.
In a twist of fate, studies even suggested that in these specific cases, B thuringiensis itself actually died in the hemolymph, meaning the B toxin's primary essential role was opening the barrier for the host's own microbiome to deliver the killing blow.
That makes the toxin a facilitator rather than the lone executioner.
That is a staggering level of specificity and complexity.
But as we established earlier, Bt is not just one protein.
It's a vast library of insecticidal molecules.
Let's shift our focus to the sheer diversity of these toxins, starting with how researchers classify them now.
Historically, classification was messy because it was based on what the toxin killed—lipidoptera, diptera, choleoptera—but that yielded inconsistent results.
Science needed a cleaner, more objective system.
Now, the classification for the delta endotoxins is based purely on the amino acid sequence homology, dividing them into two main multigenic families—Cri and CIT.
What defines each family?
A cri protein short for crystal is any parasporal inclusion protein that shows demonstrable toxic effects or, you know,
to a known cri protein.
A CIT protein short for cytolytic is defined by its ability to destroy cells, meaning it exhibits hemolytic or cytolytic activity, or has sequence similarity to known CIT proteins.
The classification relies on complex phylogenetic trees constructed from these amino acid sequences.
We don't need to get into the specific percentage thresholds for classification, but the takeaway is that when we see a designation like CRI1ab or CRI3AA, it tells us exactly where that specific toxin falls on the family tree based on its structural identity.
That's right.
The nomenclature is a detailed map of protein identity.
What's truly remarkable is that all known cri toxins, despite targeting different insect orders, share a common conserved structural topology.
Let's call it the standard cri weapon structure, which is composed of three distinct functional domains.
Yes.
Think of the cri toxin as a multi -tool, and each domain performs a separate necessary function, as shown in the protein diagrams.
Tell us about domain POG.
Domain OOV is the business end, located at the amino terminal.
It is structured as a bundle of seven helices.
Its function is to form the transmembrane pore.
This domain shares structural similarities with other pore -forming bacterial toxins, establishing it as the tool used to punch the hole.
Experiments show that if you mutate residues in this domain, the toxin can still find and bind the receptor, stage two, but it frequently fails to perform the insertion into the membrane, stage three.
So domain OOV is the hole puncher.
What about domain two?
Domain two is the recognition system.
It has a beta prism structure made of three anti -parallel sheets.
This is a major contributor to receptor binding and consequently the toxins insect specificity.
Interestingly, the structure of domain two is strikingly similar to known carbohydrate binding proteins or lectins.
This suggests that this domain evolved for precise molecular recognition of the targets on the mid gut cells.
A molecular handshake, confirming the identity of the victim.
Exactly.
If you introduce mutations in the exposed loops at the apex of domain second, you dramatically alter the kinetics of binding to the insect mid gut membranes.
This strongly suggests that the insecticidal specificity is largely determined by the specific carbohydrate signature this lectin fold recognizes.
And finally, domain three.
Domain three is the carboxyl terminal section structured like a sandwich of two twisted anti -parallel sheets.
It also shows structural similarity to other carbohydrate binding proteins like cellulose binding domains.
It is widely believed to play a role in anchoring or further specific specifically by binding to the N -acetyl galactosamine moieties that are attached to the APN receptor we discussed in stage two.
So the overall conclusion is that the insecticidal specificity is likely the result of two different lectin like domain, domain two and domain the third working together to interact with receptors on the cell surface.
It's a beautifully complex targeting mechanism.
Now let's talk about the separate family.
CIT -CIT proteins.
Remember these are produced by strains like BTI primarily toxic to the Tera larvae.
And CIT proteins are structurally very different from crya.
They are.
CIT proteins are much shorter polypeptides and they share zero amino acid sequence homology with the cry proteins.
They have an alpha beta protein structure with a three layer core contrasting sharply with the three domain cry topology.
Their receptor binding mechanism is also fundamentally different.
That's the key distinction.
CIT toxins don't target specific glycoproteins or glycolipids.
Their receptors are fundamental components of the cell membrane phospholipids, specifically phosphadilcholine, phosphatidylethanolamine, and sphingomyelin.
For toxicity to occur, the phospholipid must contain an unsaturated fatty acyl chain at a specific position.
This is the crucial linkage to their diptera specificity.
The cell membranes of diptera are significantly richer in phosphatidylethanolamine and unsaturated fatty acids compared to other insects.
How do they kill the cell?
Do they still punch a clean hole?
This is an area of ongoing debate.
There are two competing models.
The first is the pore model, suggesting that the toxin interacts with the lipid layer, undergoes a change, and forms an oligomeric transmembrane pore similar in function to the cry toxins.
The alternative is the detergent model.
This posits that cyanate proteins aggregate on the membrane surface and cause large non -specific defects in the lipid packing.
It looks like a punch and more like dissolving a hole.
Exactly.
Essentially creating a massive leaky spot on the cell surface, allowing intracellular contents to leak out.
We currently have experimental support for both models, and scientists have not yet declared one as the singular mechanism.
Before we move on to application, we have to mention the beta exatoxin because its existence caused major regulatory issues.
The beta exatoxin is an outlier in every sense.
It is a low molecular weight heat stable toxin, but it's produced during the vegetative growth phase, not sporulation.
Its structure is similar to a nucleotide, and its mechanism of action is completely different from the delta endotoxins.
It inhibits DNA dependent RNA polymerase in both bacterial and mammalian cells.
Its broad spectrum effect is why it was problematic for use against pests like the Colorado potato beetle.
Exactly.
Due to its toxicity when injected into mammals, its teratogenic effects on insects, and the regulatory sensitivity around any nucleotide -like toxin, its use as a biological control agent is prohibited in North America and Western Europe.
However, it is important to note it is used in some parts of Eastern Europe and Africa to control fly larvae in controlled environments like piggeries, at doses designed not to affect
That deep understanding of the molecular weapons sets the table for how we actually deploy them commercially.
Let's move to application, starting with the traditional use of BTI in controlling disease vectors.
B2, derived from B.
thuringiensis subs of P.
isrealensis, is one of our most successful tools here.
Its parasporal inclusions are a powerful synergistic cocktail of four toxins, three cryo -proteins cryo -4a, cryo -4b, and cryo -11a, and the cytolytic
1a1.
The synergy is key.
The combined toxic effect is far higher than what the individual proteins achieve on their own.
And BD is used globally against mosquitoes and blackflies.
Yes.
It is applied as a larvicidal treatment in their aquatic breeding sites, rice fields, ponds, salt marshes, and streams.
Since mosquitoes transmit devastating diseases like malaria, the application of BD is a critical public health strategy, particularly in tropical regions.
We noted earlier that the spore addition doesn't significantly increase BD's mortality.
That's right.
Unlike cryo -only sprays like Dipel, BD's toxicity is so crystal dependent that adding the spurs doesn't offer a significant boost in mortality.
Therefore, commercial BD preparations focus only on the toxic crystal inclusions, maximizing efficiency, and minimizing unnecessary components.
We can see a great example of this targeted application within an IPM strategy in the WHO -ontocerciosis control program targeting river blindness.
This program uses bylas strategically to prevent resistance and maximize environmental efficiency.
They use bylas heavily during the dry season when river flows are low, which minimizes the amount of product needed to achieve lethal concentrations.
Then, during the wet season, they switch to alternating chemical insecticides, like chlorphoxam or permethrin, to break the selection pressure and prevent the blackflies from evolving resistance to the biological agent.
This strategic alternation is absolutely crucial for long -term success in vector control.
Now, let's transition from sprays to the most economically impactful application.
Insect -resistant transgenic crops, which now cover vast acreage globally.
Bylas resistance is the second most common trait introduced into genetically modified crops, trailing only herbicide resistance.
Corn, cotton, and potatoes were the initial focus, targeting pests like the European corn borer, the cotton ball worm, and the Colorado potato beetle.
We generally introduce these traits using methods like particle bombardment, but for commercial -scale crops like cotton and corn, we commonly use Agrobacterium tumifatans mediated transformation, employing specialized disarmed T -plasmids.
To understand the complexity of that process, let's look closely at the development of GM Cotton Line 531,
which expresses the tri -1 egg toxin.
Line 531, the basis for many grown beet -cotton varieties, required a highly sophisticated binary plasmid vector.
This vector was essentially a modular machine containing DNA fragments sourced from bacteria, plasmids, viruses, and plants.
It was designed to function in multiple environments.
What were the key functions needed in the vector itself?
Before insertion into the plant, the plasmid needed bacterial regions to be built, maintained, and transferred.
This included regions for replication in E.
coli for initial cloning, and a separate origin of replication for its use in the A.
tumifatans delivery system.
Crucially, the vector also contained the AYA gene, which confers resistance to antibiotics like spictinomycin, allowing researchers to select for the bacteria that successfully incorporated the plasmid.
And then came the regions destined for the plant genome,
the expression cassettes.
Yes, the TDNA region contained the two main expression cassettes.
First, the plant selection cassette.
The NPTI gene, which confers canomycin resistance, allowing scientists to identify the plant cells that successfully took up the foreign DNA.
Second, the modified CARAC gene cassette, driven by a strong promoter, the PE35S promoter, which has a duplicated enhancer sequence to ensure extremely high expression levels in the plant.
Why modify the natural Crelac gene?
This is a great example of solving a biological language barrier.
The wild type bacterial Crelac gene has a high percentage of AT nucleotide pairs.
Plant DNA, however, is GC rich.
This difference can lead to poor expression efficiency in the plant host.
Scientists carefully substituted AT pairs with GC pairs to make the gene look more plant -like, optimizing its expression without significantly changing the final protein product.
The resulting cryoanac protein was 99 .4 % homologous to the original and retained the exact same insecticidal activity.
So once the vector is built, the tDNA is transferred in the cotton cell nuclei.
How does it integrate into the plant genome?
It integrates via illegitimate recombination.
This means the tDNA does not require homology or matching sequences with the plant DNA to insert.
Because of this, the integration site is inherently unpredictable and the resulting insertion pattern is often complex.
You can end up with single copies, multiple insertions, or even inverted or partial segments.
This unpredictability is precisely why comprehensive genome analysis of every new GM line is absolutely mandatory for regulatory approval.
And the analysis of line 531 revealed just how complex that integration was.
It did.
The final line 531 genome contained two distinct inserts.
A large insert contains single, full copies of the Crelac and NPTi genes, along with the AI gene.
It also contained a partial reversed Crelac segment that was inactive because it lacked a promoter.
We found that while the AI was present in the plant DNA, it was under the control of a bacterial promoter, so it was not expressed in the cotton plant.
The required regulatory hurdle for commercialization is demonstrating substantial equivalence.
This is the regulatory gold standard.
It requires the GM product to be proven, through comprehensive analysis, to be essentially equivalent in composition to its non -GM counterpart.
Line 531 demonstrated stable inheritance and critically chemical analyses showed no significant differences in protein, lipid, carbohydrate, or even existing toxic components like gossy pole compared to non -GM cotton.
With the exception of its intended insect resistance, it was equivalent and therefore approved in 1996.
We see continuous technological advancement in newer lines, like GM corn MON88017, which is both insect protected and herbicide tolerant.
This is a prime example of trait stacking.
It protects against the corn worm using the coliopterin -specific CRY3BB1 protein and also tolerates glyphosate, or roundup, through the expression of the CT4 EPSPS enzyme.
Glyphosate usually kills the plant by inhibiting its native EPSPS enzyme in the chicomate pathway.
The CP4 EPSPS variant, derived from agrobacterium Sb of Y, is resistant to glyphosate, conferring herbicide tolerance.
And this line addressed one of the major safety concerns of the earlier lines.
Absolutely.
The key feature of MON88017 is the intentional absence of introduced antibiotic resistance genes in the final transformed plant genome.
While the vector plasmid used for cloning contained the ADAD gene, southern blood analysis proved that only the tDNA region containing the CP4 EPSPS and CRY3BB1 cassettes integrated into the corn genome.
The vector backbone, including that problematic A gene, was successfully excluded.
Finally, let's look at the expression levels.
We know GM corn expresses beet toxins in all tissues, but how does the sheer quantity compare to traditional spraying?
The expression varies by tissue.
Almost 90 % of the CRY protein is typically found in the leaf tissue, for instance.
But even at high expression levels, the amount of beta toxin produced per acre is miniscule compared to chemical applications.
The research shows that the amount of CRY protein produced per acre of GM corn is the molar equivalent of more than 500 -fold less than the amount of chemical insecticide applied to the same acreage back in 1994.
The benefit of the toxin being expressed internally, continuously, and only needing a tiny amount is a master shift in environmental input.
That brings us to the final, crucial step.
The real world impact and the necessary trade -offs.
We need to assess the substantial benefits that justify this global technological shift and the genuine risks that necessitate continued vigilance.
The benefits, especially in parts of the world heavily reliant on traditional toxic chemical sprays, are undeniable and go far beyond higher yields.
Look at the data from Bright Rice trials in China.
Farmers growing insect -resistant GM rice reduced their use of chemical pesticides by over 80%.
That is a staggering reduction in chemical input.
It is.
And the human health benefit often gets overlooked.
In those village trials, a significant percentage of non -GM farming households reported adverse health effects, everything from headaches to skin irritation from pesticide use.
Among the GM rice adopters, none reported adverse health effects.
Wow.
This is a profound positive trade -off for human safety.
And the economic impacts are equally compelling, particularly in the cotton industry.
China saw a huge reduction in crop loss and a greater than 40 % decrease in overall pesticide use after commercializing beet cotton.
When we talk about assessing the risks of beet crops, we must always weigh them against the known environmental and health damage caused by traditional chemical pesticides, the millions of birds, the billions of beneficial insects, and the non -target effects they caused.
The significant decrease in those legacy inputs is arguably the largest positive trade -off of the beet technology.
Yet there are significant areas of concern that continue to drive regulatory scrutiny.
Let's start with the reliability of substantial equivalence itself.
The concern is that the processes used to generate these GM plants, the trauma of tissue culture, the gene transfer methods, and that unpredictable nature of
recombination insertion can lead to subtle undetected but significant genomic disruptions.
The insertion isn't always clean, as we saw with line 531.
That's right.
Analysis shows that more than a third of tDNA insertions actually land within existing native gene sequences, potentially disrupting natural plant function in unexpected ways.
While the standard development process screens out clones that perform poorly agronomically, that screening doesn't necessarily address potential subtle impacts on health or the
We rely heavily on substantial equivalence as a proxy for safety, but we have to recognize its inherent limitations given the messy nature of tDNA integration.
The second major area of concern, and perhaps the most high stakes,
is horizontal gene transfer, or HGT, the movement of genes to entirely different unrelated organisms.
We worry about two main directions.
First, transfer to wild relatives.
If a transferred cry gene confers a fitness advantage to a wild plant hybrid, say a beset engineered sunflower crosses with a wild relative, that wild plant might suddenly produce significantly more flower heads and seeds because it suffers reduced insect predation.
While this sounds benign, it can negatively impact the ecosystem by potentially creating superweeds or reducing the food source for beneficial native insects that rely on the wild plants.
And the second more direct human health concern is HGT to bacteria.
This is the critical issue that forced a shift in GM technology.
As we discussed, early GM lines like bull guard cotton contain the ad gene, conferring resistance to spectinomycin and streptomycin.
Given the massive scale of GM crop cultivation and the multiple routes for lateral gene transfer through soil, through animal guts, there is a legitimate and serious fear that this ad gene could jump to human pathogens.
Give us the specific real world example of what could happen.
The specific concern revolves around pathogens like Neisseria gonorrhea.
Spectinomycin is currently a crucial treatment option for N gonorrhea infections that have already developed resistance to other first line antibiotics.
If the ad gene were to transfer to this pathogen, we would lose one of our crucial last resort treatment options, severely limiting our ability to control serious infections caused by that organism.
That real threat is why there's now a strong consensus against using these markers.
Absolutely.
Thankfully, there is now a general agreement that antibiotic resistance genes should no longer be used as selectable markers in new GM plants, as alternative genetic markers are now available and in use, as we saw with the newer corn lines.
Let's discuss the risk to non -target organisms, the beneficial insects that don't need to be killed.
Extensive laboratory tests on many non -target taxa, including honeybees, ladybirds, earthworms, and mice, showed no adverse effects.
This lack of toxicity was entirely expected because these organisms lack the specific glycoprotein or glycolipid receptors necessary for the cry toxins to function.
However, the limitation of the data is still a concern.
For example, for corn, which is a major beet crop, fewer than 15 of the nearly 400 known lepidopterin species that feed on the plant have been tested for susceptibility to the expressed beet toxins.
So we have a massive blind spot regarding the tissue, but weren't the initial target.
Exactly.
Negative impacts on crucial pollinators or other dependent insect species could easily go unnoticed given the limited scope of current testing.
It highlights the need for continued,
broader ecological studies.
Finally, we have to revisit the ecological role of beet in nature because its success in agriculture seems to contradict its natural existence as a soil microbe.
This is perhaps the greatest underlying enigma.
Bi is a soil organism.
Its toxins, when sprayed on leaves, are rapidly inactivated by UV light.
It is highly unlikely to naturally encounter the specific lepidopterin or choleopterin larvae that we are now targeting through GM crops.
Yet, the bacterium spends massive amounts of energy creating these toxins, which can represent up to 10 % of the sporulating cell's total protein.
They must be contributing significantly to the bacterium's fitness.
If the targets aren't above ground insects, then who is the natural target?
The hypothesis, strongly supported by the nematode research we discussed, is that beet take co -evolved to defend itself against microscopic soil predators, specifically nematodes, which are abundant in the soil and feed on bacteria.
The toxins evolved to turn the bacteria from prey into a predator.
This suggests that the real long -term environmental impact of persistent beet toxins in our farmlands might be less about the obvious crop pests and more about the hidden ecology of the soil, demanding careful attention to how our agricultural practices are impacting these fundamental soil arthropod populations.
To synthesize this complex landscape of microbial insecticides, three ideas should absolutely stick with you, the learner.
First, while beet toxins are a vastly superior, safer alternative to persistent chemical pesticides, you must remember that they function more like highly specific chemicals than infectious agents.
They must be delivered to the host and ingested to work, and their natural capacity to spread through insect populations is low.
Second, the toxicity mechanism is a precision weapon relying on an elegant multi -stage process.
It requires alkaline dissolution in the insect gut, followed by specific proteolytic cleavage into an active toxin, highly specific high affinity binding to unique glycoprotein or glycolipid receptors, and finally poor formation in the gut lining that leads to cell destruction and allows secondary bacteria.
And third, genetically modified blight crops offer immense proven benefits, including massive yield increases and dramatic reductions in chemical pesticide use,
significantly improving farmer health and the general environment.
However, their introduction necessitates absolute regulatory vigilance regarding risks like horizontal gene transfer of resistance genes and, critically, the potential unintended consequences on non -target insect species and the foundational microbial soil environment.
That focus on the soil's hidden ecology is what I want to leave you with.
Considering that the natural purpose of brute toxins seems to be defending the bacteria against microscopic soil predators like nematodes,
how might our current large -scale agricultural use of this toxin against pests that live above ground be changing the deep, hidden microbial world of our farmlands in ways we're only just beginning to map and understand?
Thank you for joining us on this deep dive into the revolutionary science of microbial insecticides.
We hope this gave you a clear and thorough understanding of this fascinating field.
From the entire Last Minute Lecture team, thank you for tuning in.
ⓘ This audio and summary are simplified educational interpretations and are not a substitute for the original text.
Using this chapter to study? Last Minute Lecture is free and student-run. If it helped, consider supporting the project.
Support LML ♥Related Chapters
- Applications of Molecular GeneticsPrinciples of Genetics
- Bacterial Cell Structure & Key FunctionsPrescott's Microbiology
- BiomoleculesChemistry Human Activity, Chemical Reactivity
- BiotechnologyGenetics: Analysis and Principles
- Biotechnology & Industrial Microbiology ApplicationsPrescott's Microbiology
- Carbohydrate MetabolismClinical Biochemistry and Metabolic Medicine